Toriumi, S.; Kurihara, Y.; Shimokawa, K.; Tanaka, A.; Araki, N.; Kawai, O.; Sugiura, Y.; Uesawa, Y.
Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database. Pharmaceuticals 2026, 19, 688.
https://doi.org/10.3390/ph19050688
AMA Style
Toriumi S, Kurihara Y, Shimokawa K, Tanaka A, Araki N, Kawai O, Sugiura Y, Uesawa Y.
Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database. Pharmaceuticals. 2026; 19(5):688.
https://doi.org/10.3390/ph19050688
Chicago/Turabian Style
Toriumi, Shinya, Yousuke Kurihara, Komei Shimokawa, Arihito Tanaka, Norito Araki, Osamu Kawai, Yasoo Sugiura, and Yoshihiro Uesawa.
2026. "Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database" Pharmaceuticals 19, no. 5: 688.
https://doi.org/10.3390/ph19050688
APA Style
Toriumi, S., Kurihara, Y., Shimokawa, K., Tanaka, A., Araki, N., Kawai, O., Sugiura, Y., & Uesawa, Y.
(2026). Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database. Pharmaceuticals, 19(5), 688.
https://doi.org/10.3390/ph19050688
